Gastric emptying time and gastric motility in patients with Parkinson's disease
Abstract
Gastrointestinal symptoms such as nausea, abdominal pain, and bloating are frequent complaints of patients with Parkinson's disease (PD). It has been postulated that impaired gastrointestinal function may contribute to the development of motor fluctuations such as delay on and no on in patients with PD. Gastrointestinal impaired function and symptoms may be associated with the disease itself or secondary to levodopa treatment. Thus, we assessed gastric emptying (GE) and gastric motility in PD patients to examine the association between clinical status and gastric function. GE and antral contraction (frequency and amplitude) were evaluated by scintigraphy in 29 patients with mild PD (Hoehn and Yahr [H&Y] stage 1.0-2.0); 22 patients with moderate PD (H&Y stage 2.5-3.0); and 22 healthy volunteers, following the ingestion of a labeled standard meal. Gastric emptying (mean +/- SD of T(1/2)) and antral contraction were not significantly different between patients with mild PD (63.4 +/- 28.8 minutes) and moderate PD (54.7 +/- 25.5 minutes). In the control group, GE was 43.4 +/- 10.8 minutes (range 29.0 - 61.0 minutes). The prevalence of delayed emptying (>61 minutes) was not significantly different in patients with mild disease (48.3%) as compared with patients with moderate disease (36.4%). Antral contraction, both frequency and amplitude, were not significantly different between patients with mild and moderate PD throughout the entire 100 minutes of the study. Untreated patients (n = 28) had mean GE T(1/2) of 59 +/- 30.6 minutes. Patients with smooth response to levodopa showed slower GE (n = 10; 73.6 +/- 25.3 minutes), while treated patients with motor response fluctuations when tested at the on state (n = 13), had much faster GE (49.3 +/- 16.2 minutes). This shortened GE in the on state was similar to the GE of normal volunteers. We conclude that gastric emptying time in patients with PD was delayed compared with control volunteers. It was even slower in patients treated with levodopa. This effect of levodopa treatment was reversed to pseudonormalization (normal GE) at the advanced stages of the disease, when patients developed motor response fluctuation. Other clinical features of PD were not associated with delayed gastric emptying.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Delayed gastric emptying in Parkinson's disease patients dampens the proper absorption of levodopa or dopamine agonists, causing lower peak plasma concentrations and on-off fluctuations of the drug.
“Delayed gastric emptying in PD patients dampens the proper absorption of levodopa or dopamine agonists, causing lower peak plasma concentrations and on-off fluctuations of the drug (Doi et al., 2012;Hardoff et al., 2001;Marrinan et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hardoff et al., 2001
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · see citing works
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works
Biphasic nature of gastric emptying.
Siegel, J. A., Urbain, J., Adler, L., Charkes, N., Maurer, A. H., Krevsky, B., Knight, L. C., Fisher, R. S., & Malmud, L. (1988) · Gut · doi:10.1136/gut.29.1.85 · Cited by 380 · see citing works
Muenter, M. D., & Tyce, G. M. (1971) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07667-0 · Cited by 248 · see citing works
Control of on/off phenomenon by continuous intravenous infusion of levodopa
Quinn, N. P., Parkes, J. D., & Marsden, C. D. (1984) · Neurology · doi:10.1212/wnl.34.9.1131 · Cited by 232 · see citing works
Gastric emptying in Parkinson's disease
Djaldetti, R., Baron, J., Ziv, I., & Melamed, E. (1996) · Neurology · doi:10.1212/wnl.46.4.1051 · Cited by 189 · see citing works
Gastric Emptying Rate in the Elderly: Implications for Drug Therapy
Evans, M. A., Triggs, E., Cheung, M. O., Broe, G., & Creasey, H. (1981) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.1981.tb01766.x · Cited by 166 · see citing works
Soykan, İ., Sarosiek, I., Shifflett, J., Wooten, G. F., & McCallum, R. W. (1997) · Movement Disorders · doi:10.1002/mds.870120618 · Cited by 163 · see citing works
Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
Yeh, K. C., August, T. F., Bush, D., Lasseter, K. C., Musson, D. G., Schwartz, S. E., Smith, M. E., & Titus, D. C. (1989) · PubMed · Cited by 161 · see citing works
Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observations
Kurlan, R., Rubin, A. J., Miller, C. D., Rivera‐Calimlim, L., Clarke, A., & Shoulson, I. (1986) · Annals of Neurology · doi:10.1002/ana.410200213 · Cited by 140 · see citing works
Gastrointestinal symptoms in parkinson disease: 18‐month follow‐up study
Edwards, L. L., Quigley, E. M. M., Hofman, R., & Pfeiffer, R. F. (1993) · Movement Disorders · doi:10.1002/mds.870080115 · Cited by 129 · see citing works
The two-component stomach: effects of meal particle size on fundal and antral emptying
Urbain, J.-L., Siegel, J. A., Charkes, N. D., Maurer, A. H., Malmud, L. S., & Fisher, R. S. (1989) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00257543 · Cited by 120 · see citing works
Long‐term duodenal infusion of levodopa for motor fluctuations in parkinsonism
Sage, J. I., Trooskin, S. Z., Sonsalla, P. K., Heikkila, R. E., & Duvoisin, R. C. (1988) · Annals of Neurology · doi:10.1002/ana.410240116 · Cited by 120 · see citing works
Loewy, A. D., Franklin, M., & Haxhiu, M. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90657-2 · Cited by 98 · see citing works
Cerebral vasocapacitance and TIAs
Levine, R. L., Lagrèze, H. L., Dobkin, J. A., Hanson, J. M., Satter, M., Rowe, B. R., & Nickles, R. J. (1989) · Neurology · doi:10.1212/wnl.39.1.25 · Cited by 95 · see citing works
The influence of levodopa on gastric emptying in man.
Robertson, D., Renwick, A., Wood, N., Cross, N. C. P., Macklin, B., Fleming, J. S., Waller, D., & George, C. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03601.x · Cited by 73 · see citing works
Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient
Evans, M. A., Broe, G. A., TRIGGS, E. J., Cheung, M., Creasey, H. M., & Paull, P. (1981) · Neurology · doi:10.1212/wnl.31.10.1288 · Cited by 71 · see citing works
Absorption and Metabolism of Levodopa
Abrams, W. B. (1971) · JAMA · doi:10.1001/jama.1971.03190260028007 · Cited by 67 · see citing works
Effect of cisapride on response fluctuations in Parkinson's disease
Djaldetti, R., Koren‐Michowitz, M., Ziv, I., Achiron, A., & Melamed, E. (1995) · Movement Disorders · doi:10.1002/mds.870100113 · Cited by 58 · see citing works
Interaction of levodopa and metoclopramide on gastric emptying
Berkowitz, D. M., & McCallum, R. W. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.55 · Cited by 58 · see citing works
Chronic levodopa therapy enhances dopa absorption: Contribution to wearing-off
Murata, M., Mizusawa, H., Yamanouchi, H., & Kanazawa, I. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271202 · Cited by 53 · see citing works
Recent advances in gastric emptying scintigraphy
Urbain, J.-L., & Charkes, N. D. (1995) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(95)80005-0 · Cited by 51 · see citing works
Murata, M., & Kanazawa, I. (1993) · Neuroscience Research · doi:10.1016/0168-0102(93)90004-a · Cited by 47 · see citing works
Basic mechanisms of motor fluctuations.
Sage, J., & Mark, M. H. (1994) · PubMed · Cited by 42 · see citing works
Comparison of left anterior oblique and geometric mean gastric emptying.
Maurer, A. H., Lc, K., Charkes, N. D., Vitti, R. A., Krevsky, B., Fisher, R. S., & Ja, S. (1991) · PubMed · Cited by 39 · see citing works
Diets affecting treatment of parkinsonism with levodopa1
Gillespie, N., Mena, I. F., Cotzias, G. C., & Bell, M. A. (1973) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)08917-3 · Cited by 33 · see citing works
Maqbool, A., Batten, T. F. C., Berry, P., & McWilliam, P. N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90619-q · Cited by 33 · see citing works
Haptoglobin Subtypes among Four Different Populations
Mastana, S. S., Bernal, J. E., Onyemelukwe, G. C., & Papiha, S. S. (1994) · Human Heredity · doi:10.1159/000154182 · Cited by 24 · see citing works
Ruggiero, D. A., Chau, L., Anwar, M., Mtui, E. P., & Golanov, E. V. (1993) · Brain Research · doi:10.1016/0006-8993(93)90607-o · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · see citing works
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021 · see citing works
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925 · see citing works
Parkinson's Disease and Parkinsonism
Hayes, M. T. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.001 · Cited by 823 · see citing works
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716 · see citing works
Our gut microbiome: The evolving inner self
Kundu, P., Blacher, E., Elinav, E., & Pettersson, S. (2017) · Cell · doi:10.1016/j.cell.2017.11.024 · Cited by 633 · see citing works
Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
LeWitt, P. A. (2015) · Movement Disorders · doi:10.1002/mds.26082 · Cited by 379 · see citing works
Role of microbiota-derived short-chain fatty acids in nervous system disorders
Mirzaei, R., Bouzari, B., Hosseini‐Fard, S. R., Mazaheri, M., Ahmadyousefi, Y., Abdi, M., Jalalifar, S., Karimitabar, Z., Teimoori, A., Keyvani, H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111661 · Cited by 400 · see citing works
Vagal neurocircuitry and its influence on gastric motility
Travagli, R. A., & Anselmi, L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.76 · Cited by 323 · see citing works
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303 · see citing works
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298 · see citing works
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266 · see citing works
Neuroprotective Effects of Coffee Bioactive Compounds: A Review
Socała, K., Szopa, A., Serefko, A., Poleszak, E., & Właź, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010107 · Cited by 263 · see citing works
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Alam, M., Ahmed, S., Elasbali, A. M., Adnan, M., Alam, S., Hassan, M. I., & Pasupuleti, V. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860508 · Cited by 234 · see citing works
Gastrointestinal dysfunction in Parkinson's Disease
Jost, W. H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.020 · Cited by 222 · see citing works
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203 · see citing works
Sexual Dysfunction in Parkinson's Disease
Bronner, G., Royter, V., Korczyn, A. D., & Giladi, N. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490258893 · Cited by 188 · see citing works
Self-citationNeural control of the gastrointestinal tract: Implications for Parkinson disease
Cersosimo, M. G., & Benarroch, E. E. (2008) · Movement Disorders · doi:10.1002/mds.22051 · Cited by 188 · see citing works
No evidence for decreased incidence of aspiration after rapid sequence induction
Neilipovitz, D., & Crosby, E. T. (2007) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03026872 · Cited by 183 · see citing works
Gastroparesis and Parkinson’s disease: a systematic review
Heetun, Z. S., & Quigley, E. M. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.004 · Cited by 182 · see citing works
Greene, J. G., Noorian, A. R., & Srinivasan, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.023 · Cited by 165 · see citing works
Pharmacokinetic Optimisation in the Treatment of Parkinson???s Disease
Nyholm, D. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00001 · Cited by 163 · see citing works
Brainstem pathology and non-motor symptoms in PD
Grinberg, L. T., Rueb, U., Alho, A. T. D. L., & Heinsen, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.021 · Cited by 162 · see citing works
Delayed gastric emptying in Parkinson's disease
Marrinan, S. L., Emmanuel, A. V., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25708 · Cited by 157 · see citing works
Gjerløff, T., Fedorova, T. D., Knudsen, K., Munk, O. L., Nahimi, A., Jacobsen, S., Danielsen, E. H., Terkelsen, A. J., Hansen, J., Pavese, N., et al. (2014) · Brain · doi:10.1093/brain/awu369 · Cited by 157 · see citing works
Probiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 152 · see citing works
Predictors of gastric emptying in Parkinson's disease
Goetze, O., Nikodem, A., Wiezcorek, J., Banasch, M., Przuntek, H., Mueller, T. J., Schmidt, W. E., & Woitalla, D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00780.x · Cited by 146 · see citing works
Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients
M�ller, T., Erdmann, C., Bremen, D., Schmidt, W. E., Muhlack, S., Woitalla, D., & Goetze, O. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00001 · Cited by 131 · see citing works
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130 · see citing works
Natale, G., Pasquali, L., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01162.x · Cited by 129 · see citing works
Quantitative study of salivary secretion in Parkinson's disease
Tumilasci, O. R., Cersosimo, M. G., Belforte, J. E., Micheli, F. E., Benarroch, E. E., & Pazo, J. H. (2006) · Movement Disorders · doi:10.1002/mds.20784 · Cited by 128 · see citing works
Multi-organ autonomic dysfunction in Parkinson disease
Jain, S. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.022 · Cited by 117 · see citing works
Goetze, O., Wieczorek, J., Mueller, T. J., Przuntek, H., Schmidt, W. E., & Woitalla, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.007 · Cited by 116 · see citing works
Wang, L., Magen, I., Yuan, P. Q., Subramaniam, S., Richter, F., Chesselet, M. ‐., & Taché, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01974.x · Cited by 115 · see citing works
Irregular gastrointestinal drug absorption in Parkinson's disease
Nyholm, D., & Lennernäs, H. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.193 · Cited by 115 · see citing works
Clinical outcome of deep brain stimulation for Parkinson's disease.
Deuschl, G., Paschen, S., & Witt, K. (2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53497-2.00010-3 · Cited by 105 · see citing works
Slevin, J. T., Fernandez, H. H., Zadikoff, C., Hall, C. M., Eaton, S., Dubow, J. S., Chatamra, K., & Benesh, J. A. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140456 · Cited by 106 · see citing works
Effects of dopaminergic treatment on bladder function in Parkinson's disease
Winge, K., Werdelin, L., Nielsen, K. K., & Stimpel, H. (2004) · Neurourology and Urodynamics · doi:10.1002/nau.20054 · Cited by 101 · see citing works
Treatment of Advanced Parkinson's Disease
Varanese, S., Birnbaum, Z. E., Rossi, R. P., & Rocco, A. D. (2010) · Parkinson s Disease · doi:10.4061/2010/480260 · Cited by 100 · see citing works
Zis, P., Erro, R., Walton, C. C., Sauerbier, A., & Chaudhuri, К. R. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.13 · Cited by 98 · see citing works
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease
Arai, E., Arai, M., Uchiyama, T., Higuchi, Y., Aoyagi, K., Yamanaka, Y., Yamamoto, T., Nagano, O., Shiina, A., Maruoka, D., et al. (2012) · Brain · doi:10.1093/brain/aws086 · Cited by 90 · see citing works
Gastrointestinal Dysfunction in Parkinson’s Disease
Skjærbæk, C., Knudsen, K., Horsager, J., & Borghammer, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030493 · Cited by 84 · see citing works
Herbert, M. K., & Holzer, P. D. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.08.001 · Cited by 84 · see citing works
Tian, Y.-M., Chen, X., Luo, D.-Z., Zhang, X.-H., Xue, H., Zheng, L.-F., Yang, N., Wang, X.-M., & Zhu, J.-X. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.033 · Cited by 84 · see citing works
Schaeffer, E., Kluge, A., Bottner, M. B., Zunke, F., Cossais, F., Berg, D., & Arnold, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.573696 · Cited by 84 · see citing works
Zheng, L., Song, J., Fan, R. ‐., Chen, C. ‐., Ren, Q. ‐., Zhang, X. ‐., Feng, X., Zhang, Y., Li, L. ‐., & Zhu, J. (2014) · Acta Physiologica · doi:10.1111/apha.12229 · Cited by 80 · see citing works
Dobbs, R. J., Dobbs, S. M., Weller, C., Bjarnason, I., Oxlade, N. L., Charlett, A., Al-Janabi, M., Kerwin, R. W., Mahler, R. F., & Price, A. B. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00331.x · Cited by 79 · see citing works
Noorian, A. R., Rha, J., Annerino, D. M., Bernhard, D., Taylor, G. M., & Greene, J. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.005 · Cited by 79 · see citing works
Clinical aspects of Parkinson disease
Sethi, K. D. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00009 · Cited by 78 · see citing works
Metheny, N. A. (2002) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710202600605 · Cited by 78 · see citing works
Zhu, H. C., Zhao, J., Luo, C. Y., & Li, Q. Q. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9560-0 · Cited by 77 · see citing works
Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease
Kim, J.-S., & Sung, H.-Y. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15008 · Cited by 76 · see citing works
Zheng, L., Wang, Z.-Y., Li, X., Jin, S., Hong, F., Lian, H., Wang, Q., Feng, X., Tang, Y., Zhang, Y., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.09.006 · Cited by 73 · see citing works
Tanaka, Y., Kato, T., Nishida, H., Yamada, M., Koumura, A., Sakurai, T., Hayashi, Y., Kimura, A., Hozumi, I., Araki, H., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5769-z · Cited by 73 · see citing works
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence
Pellegrini, C., Antonioli, L., Colucci, R., Ballabeni, V., Barocelli, E., Bernardini, N., Blandizzi, C., & Fornai, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.011 · Cited by 73 · see citing works
Clinical implications of gastric complications on levodopa treatment in Parkinson’s disease
Pfeiffer, R. F., Isaacson, S. H., & Pahwa, R. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.001 · Cited by 77 · see citing works
Antonini, A., Chaudhuri, К. R., Martínez‐Martín, P., & Odin, P. (2010) · CNS Drugs · doi:10.2165/11310940-000000000-00000 · Cited by 71 · see citing works
Transdermal Treatment Options for Neurological Disorders
Priano, L., Gasco, M. R., & Mauro, A. (2006) · Drugs & Aging · doi:10.2165/00002512-200623050-00001 · Cited by 71 · see citing works
Gastric Mixing During Food Digestion: Mechanisms and Applications
Bornhorst, G. M. (2017) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030216-025802 · Cited by 69 · see citing works
Gastrointestinal features of Parkinson’s disease
Cloud, L. J., & Greene, J. G. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0204-0 · Cited by 67 · see citing works
Levodopa Infusion Therapy in Parkinson Disease
Nyholm, D., & Aquilonius, S. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000144041.28224.b7 · Cited by 66 · see citing works
Greene, J. G. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5859 · Cited by 66 · see citing works
Standaert, D. G., Rodriguez, R. L., Slevin, J. T., Lobatz, M., Eaton, S., Chatamra, K., Facheris, M., Hall, C. M., Sail, K., Jalundhwala, Y. J., et al. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12526 · Cited by 63 · see citing works
Gastric emptying after semi–solid food in multiple system atrophy and Parkinson disease
Thomaides, T., Karapanayiotides, T., Zoukos, Y., Haeropoulos, C., Kerezoudi, E., Demacopoulos, N., Floodas, G., Papageorgiou, E., Armakola, F., Thomopoulos, Y., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0815-y · Cited by 60 · see citing works
Karasawa, H., Pietra, C., Giuliano, C., García-Rubio, S., Xu, X., Yakabi, S., Taché, Y., & Wang, L.-X. (2014) · Neurogastroenterology and Motility · doi:10.1111/nmo.12459 · Cited by 62 · see citing works
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 60 · see citing works
Helicobacter pylori eradication for Parkinson's disease
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., & Ben-Shlomo, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008453.pub2 · Cited by 56 · see citing works
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies
Politi, C., Ciccacci, C., Novelli, G., & Borgiani, P. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8473-7 · Cited by 56 · see citing works
Systems Approach to Neurodegenerative Disease Biomarker Discovery
Lausted, C. G., Lee, I., Zhou, Y. F., Qin, S., Sung, J., Price, N. D., Hood, L., & Wang, K. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135928 · Cited by 52 · see citing works
Gastric emptying in Parkinson's disease – A mini-review
Knudsen, K., Szwebs, M., Hansen, A. K., & Borghammer, P. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.06.003 · Cited by 49 · see citing works
Ghaisas, S., Langley, M. R., Palanisamy, B. N., Dutta, S., Kirthi, N., Plummer, P. J., Sarkar, S., Ay, M., Jin, H., Anantharam, V., et al. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.004 · Cited by 49 · see citing works
Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management
Soliman, H., Coffin, B., & Gourcerol, G. (2021) · Brain Sciences · doi:10.3390/brainsci11070831 · Cited by 52 · see citing works
Bencsik, A., Muselli, L., Leboidre, M., Lakhdar, L., & Baron, T. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000137 · Cited by 48 · see citing works
Delayed Gastric Emptying in Advanced Parkinson Disease
BESTETTI, A., Capozza, A., Lacerenza, M. R., Manfredi, L., & Mancini, F. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001470 · Cited by 48 · see citing works
Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study
Fasano, A. A., Gurevich, T., Jech, R., Kovács, N., Svenningsson, P., Szász, J. A., Parra, J. C., Bergmann, L., Johnson, A., Sánchez‐Soliño, O., et al. (2021) · Movement Disorders · doi:10.1002/mds.28596 · Cited by 48 · see citing works
The effects of a normal protein diet on LevoDOPA plasma kinetics in advanced Parkinson's disease
Simon, N., Gantcheva, R., Bruguerolle, B., & Viallet, F. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.10.004 · Cited by 46 · see citing works
Model-based dietary optimization for late-stage, levodopa-treated, Parkinson’s disease patients
Guebila, M. B., & Thiele, I. (2016) · npj Systems Biology and Applications · doi:10.1038/npjsba.2016.13 · Cited by 45 · see citing works
Orimo, S., Ghebremedhin, E., & Gelpí, E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2851-9 · Cited by 46 · see citing works
Microbial treatment: the potential application for Parkinson’s disease
Fang, X. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3641-6 · Cited by 45 · see citing works
A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease
Ceravolo, R., Rossi, C., Del Prete, E., & Bonuccelli, U. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1130128 · Cited by 44 · see citing works
Pellegrini, C., Colucci, R., Antonioli, L., Barocelli, E., Ballabeni, V., Bernardini, N., Blandizzi, C., de Jonge, W. J., & Fornai, M. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12933 · Cited by 41 · see citing works
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
Perez‐Pardo, P., Broersen, L. M., Kliest, T., van Wijk, N., Attali, A., Garssen, J., & Kraneveld, A. D. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00237 · Cited by 40 · see citing works
Unger, M. M., Hattemer, K., Möller, J. C., Schmittinger, K., Mankel, K., Eggert, K. M., Strauch, K., Tebbe, J. J., Keil, B. R., Oertel, W. H., et al. (2010) · Movement Disorders · doi:10.1002/mds.22841 · Cited by 40 · see citing works
A promising new technology for Parkinson’s disease
Pfeiffer, R. F. (2005) · Neurology · doi:10.1212/wnl.65.2_suppl_1.s6 · Cited by 38 · see citing works
Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease
Pfeiffer, R. F. (2010) · Movement Disorders · doi:10.1002/mds.22715 · Cited by 38 · see citing works
Steiger, M. J. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01674.x · Cited by 38 · see citing works
Guimarães, M., Statelova, M., Holm, R., Reppas, C. I., Symillides, M., Vertzoni, M., & Fotaki, N. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12955 · Cited by 37 · see citing works
Botulinum toxin type A for the treatment of gastroparesis in Parkinson’s disease patients
Gil, R. A., Hwynn, N., Fabian, T., Joseph, S., & Fernandez, H. H. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.007 · Cited by 35 · see citing works
Krüger, R., Lingor, P., Doskas, T. K., Henselmans, J. M. L., Danielsen, E. H., de Fàbregues, O., Stefani, A., Sensken, S.-C., Parra, J. C., Onuk, K., et al. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0571-2 · Cited by 32 · see citing works
A mechanism-Based Approach for Absorption Modeling: The Gastro-Intestinal Transit Time (GITT) Model
Hénin, É., Bergstrand, M., Standing, J. F., & Karlsson, M. O. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9324-y · Cited by 31 · see citing works
Rieck, M., Schuh, A. F. S., Altmann, V., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.79 · Cited by 29 · see citing works
Kuhar, S., Lee, J. H., Seo, J.-H., Pasricha, P. J., & Mittal, R. (2022) · Physics of Fluids · doi:10.1063/5.0120933 · Cited by 28 · see citing works
Bhidayasiri, R., Phuenpathom, W., Tan, A. H., Leta, V., Phumphid, S., Chaudhuri, К. R., & Pal, P. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979826 · Cited by 28 · see citing works
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Schröter, N., Sajonz, B., Jost, W. H., Rijntjes, M., Coenen, V. A., & Groppa, S. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02773-3 · Cited by 28 · see citing works
Woitalla, D., Kassubek, J., Timmermann, L., Lauterbach, T., Berkels, R., Grieger, F., & Müller, T. H. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.11.024 · Cited by 27 · see citing works
Kenna, J. E., Bakeberg, M. C., Gorecki, A. M., Tay, C. Y., Winter, S., Mastaglia, F. L., & Anderton, R. S. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13134 · Cited by 27 · see citing works
Othman, A. A., Chatamra, K., Mohamed, M. F., Dutta, S., Benesh, J. A., Yanagawa, M., & Nagai, M. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0265-3 · Cited by 27 · see citing works
Between-meal risedronate does not alter bone turnover in nursing home residents
Agrawal, S., Krueger, D. C., Engelke, J. A., Nest, L. J., Krause, P. F., Drinka, P. J., & Binkley, N. C. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00696.x · Cited by 26 · see citing works
Chen, C., Cowles, V. E., Sweeney, M. L., Stolyarov, I. D., & Illarioshkin, S. N. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31824523de · Cited by 26 · see citing works
Unger, M. M., Möller, J. C., Mankel, K., Schmittinger, K., Eggert, K. M., Stamelou, M., Stiasny‐Kolster, K., Bohne, K., Bodden, M., Mayer, G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23933 · Cited by 26 · see citing works
- Authors
- Hardoff, R., Sula, M., Tamir, A., Soil, A., Front, A., Badarna, S., Honigman, S., & Giladi, N.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Hardoff, Ruth
- ORCID
- Giladi, Nir
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2001-11
- Volume
- 16
- Issue
- 6
- Pages
- 1041-1047
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1991349201
- Cited by
- 248
- References
- 29
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 11 · 2021: 16 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 11 · 2016: 23 · 2015: 15 · 2014: 14 · 2013: 7 · 2012: 9
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- Parkinson's disease, gastric emptying, gastric motility, antral contractions, levodopa, motor fluctuations, delayed gastric emptying, gastrointestinal symptoms, Hoehn and Yahr stage, scintigraphy, pseudonormalization, on-off phenomenon, levodopa response
- MeSH terms
- Aged, Antiparkinson Agents, Female, Gastric Emptying, Gastrointestinal Motility, Humans, Levodopa, Male, Middle Aged, Parkinson Disease, Severity of Illness Index, Technetium Tc 99m Aggregated Albumin, Tomography, Emission-Computed, Case-Control Studies, Disease Progression, Radiopharmaceuticals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review